Janux Therapeutics Inc. (JANX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
46.83
1.48 (3.26%)
At close: Jan 15, 2025, 10:24 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | 8.08M | 8.61M | 3.64M | n/a | n/a |
Cost of Revenue | 1.96M | 841.00K | 113.00K | 13.00K | 6.00K |
Gross Profit | 6.13M | 7.77M | 3.52M | -13.00K | -6.00K |
Operating Income | -72.98M | -67.09M | -32.93M | -4.84M | -3.77M |
Interest Income | 14.69M | 4.03M | 257.00K | 206.00K | 233.00K |
Pretax Income | -58.29M | -63.06M | -32.67M | -6.78M | -4.00M |
Net Income | -58.29M | -54.15M | -32.56M | -5.25M | -4.24M |
Selling & General & Admin | 26.14M | 22.26M | 10.33M | 1.80M | 772.00K |
Research & Development | 54.92M | 53.44M | 26.24M | 3.04M | 3.00M |
Other Expenses | n/a | 4.03M | 257.00K | -1.74M | n/a |
Operating Expenses | 81.06M | 75.70M | 36.57M | 4.84M | 3.77M |
Interest Expense | n/a | 4.03M | n/a | 206.00K | 233.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 81.06M | 75.70M | 36.57M | 4.84M | 3.77M |
Income Tax | n/a | -8.90M | -113.00K | -1.53M | 233.00K |
Shares Outstanding (Basic) | 44.02M | 41.47M | 41.24M | 41.61M | 41.61M |
Shares Outstanding (Diluted) | 44.02M | 41.47M | 41.24M | 41.61M | 41.61M |
EPS (Basic) | -1.32 | -1.31 | -0.79 | -0.13 | -0.1 |
EPS (Diluted) | -1.32 | -1.31 | -0.79 | -0.13 | -0.1 |
EBITDA | -71.02M | -66.25M | -32.82M | -4.83M | -3.77M |
Depreciation & Amortization | 1.96M | 841.00K | 113.00K | 13.00K | 6.00K |